Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Analytical Method Development: Total Organic Carbon (TOC) Method Development – V 2.0

Posted on By

Analytical Method Development: Total Organic Carbon (TOC) Method Development – V 2.0

SOP for Total Organic Carbon (TOC) Method Development in AMD Laboratory


Department Analytical Method Development
SOP No. SOP/AMD/056/2025
Supersedes SOP/AMD/056/2022
Page No. Page 1 of 14
Issue Date 19/05/2025
Effective Date 20/05/2025
Review Date 19/05/2026

1. Purpose

This SOP defines the procedure for the development, optimization, and validation of analytical methods for Total Organic Carbon (TOC) determination using TOC

analyzers. It applies to analysis of water samples, cleaning validation swabs, rinse samples, and other low-carbon pharmaceutical matrices.

2. Scope

This SOP is applicable to the Analytical Method Development (AMD) department for TOC method development using combustion or UV-persulfate oxidation-based analyzers for pharmaceutical water systems, cleaning validation, and process monitoring, in accordance with USP <643>, EP 2.2.44, and ICH Q2(R1).

3. Responsibilities

  • Analytical Scientist: Prepares calibration and sample solutions, operates the TOC analyzer, and documents results.
  • Reviewer: Verifies raw data, calibration curves, and validation reports for accuracy and compliance.
  • QA Officer: Ensures documentation adherence to GMP, USP, and ICH guidelines.
  • Head – AMD: Approves validated methods for use in routine analysis or cleaning validation programs.

4. Accountability

The Head of Analytical Method Development is accountable for ensuring that TOC methods are properly developed, validated, and documented in compliance with applicable regulatory requirements.

5. Procedure

5.1 Principle of TOC Analysis

  1. TOC analysis involves measuring the carbon content of organic compounds in aqueous solutions by converting them to CO2 and detecting the carbon dioxide using:
    • Non-dispersive infrared (NDIR) detection (for combustion analyzers)
    • Conductivity detection (for UV-persulfate oxidizers)
  2. The result is expressed in ppm or ppb of carbon (mg/L or µg/L).

5.2 Instrument and Calibration Setup

  1. Switch ON the TOC analyzer and allow system warm-up (30–60 minutes).
  2. Perform auto-calibration using standard solutions:
    • 0 ppm (blank)
    • 1 ppm
    • 5 ppm
    • 10 ppm
  3. Use potassium hydrogen phthalate (KHP) or sucrose as calibration standards.
  4. Ensure R² ≥ 0.999 for linearity across calibration curve.
  5. Document all calibration results in Annexure-1: TOC Calibration Log.

5.3 Sample Preparation and Handling

  1. Use only TOC-grade water, glassware, and swabs.
  2. Ensure no carbon contamination from sample containers or atmospheric exposure.
  3. Swab samples (for cleaning validation):
    • Use pre-rinsed low-carbon swabs
    • Extract swab into 10 mL TOC water for 30 minutes
  4. Rinse samples:
    • Collect 100–200 mL final rinse water from equipment surface
  5. Store samples at 2–8°C and analyze within 24 hours.
  6. Document in Annexure-2: Sample Log Sheet.

5.4 System Suitability and Blank Check

  1. Before sample analysis, inject blank (TOC water) to confirm background < 50 ppb.
  2. Inject mid-level standard (5 ppm) three times:
    • % RSD of response should be ≤ 2.0%
  3. Perform system suitability check daily before sample testing.
  4. Document results in Annexure-3: System Suitability Record.

5.5 Method Optimization

  1. Evaluate:
    • Combustion vs. UV-persulfate oxidation efficiency
    • Sample volume (typically 30–50 µL)
    • Inlet rinse cycles to reduce memory effects
    • Interference from inorganic carbon (IC) and proper IC removal method (acidification and purging)
  2. Optimize number of replicate injections (min. 3) and auto-sampler rinse cycles.
  3. Record optimization trials in Annexure-4: Method Optimization Log.

5.6 Method Validation

  1. Linearity: 0.1 to 10 ppm range; R² ≥ 0.999
  2. Accuracy: Spike recovery between 95%–105%
  3. Precision:
    • Repeatability: RSD ≤ 2.0% for 6 replicates
    • Intermediate Precision: Two analysts/days
  4. LOD & LOQ: Determine based on standard deviation of low-level replicates
  5. Specificity: Confirm negligible interference from matrix or excipients
  6. Robustness: Vary purge time, sample volume, and IC removal parameters
  7. Document in Annexure-5: Validation Summary Report.

5.7 Final Method Documentation

  1. Compile finalized method including:
    • System settings and oxidation mode
    • Calibration range and standard prep
    • Sample prep guidelines for different matrices
    • Acceptable criteria for cleaning validation
    • System suitability and troubleshooting
  2. Submit final method to QA for review and approval.

6. Abbreviations

  • TOC: Total Organic Carbon
  • KHP: Potassium Hydrogen Phthalate
  • RSD: Relative Standard Deviation
  • LOD: Limit of Detection
  • LOQ: Limit of Quantification
  • NDIR: Non-Dispersive Infrared

7. Documents

  1. TOC Calibration Log – Annexure-1
  2. Sample Log Sheet – Annexure-2
  3. System Suitability Record – Annexure-3
  4. Method Optimization Log – Annexure-4
  5. Validation Summary Report – Annexure-5

8. References

  • USP <643> – Total Organic Carbon
  • EP 2.2.44 – TOC in Pharmaceutical Waters
  • ICH Q2(R1) – Validation of Analytical Procedures
  • FDA Cleaning Validation Guidance (2021)

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: TOC Calibration Log

Standard (ppm) Response Average R²
0.0, 1.0, 5.0, 10.0 Auto-injected Valid 0.9997

Annexure-2: Sample Log Sheet

Sample Type ID Volume (mL) Storage Temp Analyzed By
Rinse Water TOC-RW-102 100 2–8°C Sunita Reddy

Annexure-3: System Suitability Record

Injection TOC (ppm)
1 5.01
2 4.98
3 5.02

Annexure-4: Method Optimization Log

Trial Parameter Setting Observation Conclusion
1 Purging Time 6 min IC effectively removed Accepted

Annexure-5: Validation Summary Report

Parameter Criteria Result Status
Accuracy 95–105% 98.7% Pass
Precision RSD ≤ 2% 1.1% Pass
LOD Estimated 0.02 ppm Pass

Revision History:

Revision Date Revision No. Details Reason Approved By
04/05/2025 2.0 Integrated swab and rinse procedures with expanded validation scope Annual SOP Review
See also  Analytical Method Development: System Suitability Testing Parameters Design - V 2.0
Analytical Method Development V 2.0 Tags:Analytical Method Development SOP, SOP for analytical calculations, SOP for analytical documentation, SOP for analytical instrument calibration, SOP for analytical instrument qualification, SOP for analytical method change control, SOP for analytical method deviation handling, SOP for analytical method documentation practices, SOP for analytical method lifecycle management, SOP for analytical method optimization, SOP for analytical method risk assessment, SOP for analytical method training and competency, SOP for analytical method transfer protocol, SOP for analytical method validation, SOP for forced degradation studies, SOP for HPLC method development, SOP for limit of detection (LOD) determination, SOP for limit of quantitation (LOQ) determination, SOP for method accuracy testing, SOP for method linearity assessment, SOP for method precision evaluation, SOP for method reproducibility, SOP for method robustness testing, SOP for method transfer, SOP for method verification, SOP for qualification of working standards, SOP for reference standard handling, SOP for specificity testing in analytical methods, SOP for stability indicating methods, SOP for system suitability testing

Post navigation

Previous Post: BA-BE Studies: SOP for Creating Clinical Site Master File – V 2.0
Next Post: API Manufacturing: SOP for Stage-Wise Approval of API Manufacturing – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version